Search

Repligen Corp

Slēgts

SektorsVeselības aprūpe

166.1 -0.46

Pārskats

Akcijas cenas izmaiņa

24h

Šī brīža

Min

163.91

Max

167.8

Galvenie mērījumi

By Trading Economics

Ienākumi

-3.3M

5M

Pārdošana

9.9M

204M

P/E

Sektora vidējais

223.521

57.002

EPS

0.54

Peļņas marža

2.453

Darbinieki

2,000

EBITDA

-35M

-2.4M

Rekomendācijas

By TipRanks

Rekomendācijas

Pirkt (spēcīgs)

Prognoze 12 mēnešiem

+2.96% upside

Dividendes

By Acuity

Nākamie ieņēmumi

2026. g. 27. okt.

Tirgus statistika

By TradingEconomics

Tirgus kapitalizācija

1.8B

9.2B

Iepriekšējā atvēršanas cena

166.56

Iepriekšējā slēgšanas cena

166.1

Ziņu noskaņojums

By Acuity

50%

50%

163 / 340 Rangs Healthcare

Repligen Corp Grafiks

Pagātnes rezultāti nav uzticams nākotnes rezultātu rādītājs.

Saistītās ziņas

2026. g. 14. aug. 19:16 UTC

Repligen Corp shares are lower today amid a lack of specific news. Investor sentiment is cautious following a decline in U.S. retail sales.

2026. g. 13. aug. 22:01 UTC

Repligen Corp shares are lower in after-market hours, dropping from a brief high. The price remains above its 20-day moving average.

2026. g. 12. aug. 19:36 UTC

Repligen Corp shares are higher today amid broader market optimism following a modest increase in the core Consumer Price Index. No specific company news was identified.

2026. g. 11. aug. 20:01 UTC

Repligen Corp shares are higher today, reflecting strong performance amid routine trading. The stock remains above its 20-day moving average.

2026. g. 10. aug. 23:16 UTC

Repligen Corp shares are trading higher in after-market hours. The stock remains near the upper end of its one-month trading range.

2026. g. 7. aug. 22:01 UTC

Repligen Corp shares are higher in after-market trading, continuing a trend of six consecutive sessions. Broader equity gains follow weaker employment data easing rate hike concerns.

2026. g. 6. aug. 20:02 UTC

Repligen Corp shares are higher today, continuing gains from Wednesday. No specific company news was identified to explain the movement.

2026. g. 5. aug. 20:02 UTC

Correlated Moves

Repligen Corp shares are higher today, bolstered by gains in Charles River Laboratories and positive sentiment in the life sciences sector.

2026. g. 4. aug. 19:56 UTC

Repligen Corp shares are higher today, reflecting broader market strength amid a significant decline in crude oil prices. The stock is near its one-month range's upper end.

2026. g. 31. jūl. 20:02 UTC

Repligen Corp shares are lower today amid broader market pressures and rising US Treasury yields. The stock reached a session low earlier.

2026. g. 30. jūl. 21:02 UTC

Repligen Corp shares are higher in after-market trading, buoyed by positive investor sentiment amid a focus on corporate earnings and broader market trends.

2026. g. 29. jūl. 16:12 UTC

Repligen Corp shares are lower Wednesday, breaking a trend of higher daily closes. Broader market conditions reflect rising crude oil prices and inflation concerns.

2026. g. 28. jūl. 23:21 UTC

Repligen Corp shares are higher in after-market trading, reflecting strong momentum and trading near the upper end of its one-month range.

2026. g. 27. jūl. 16:26 UTC

News

Repligen Corporation shares are lower as the company approaches its Q2 earnings report, with analysts projecting 10.7% revenue growth. Current price is $131.96.

2026. g. 24. jūl. 19:06 UTC

News

Repligen Corp is under scrutiny as a stock to avoid, with concerns over its $763.3 million revenue and declining operating margins. Shares are trading lower today.

2026. g. 22. jūl. 19:25 UTC

News
Event
Social Media

Repligen Corp is acquiring BioLife Solutions for about $1.5 billion, offering $11.25 in cash and stock, with a projected $20 million in synergies.

2026. g. 21. jūl. 22:56 UTC

Repligen Corp shares are higher in after-market trading, despite a recent trend of lower closes. Broader market sentiment may be influenced by the Nikkei 225 surge.

2026. g. 20. jūl. 18:06 UTC

Repligen Corp shares are higher today, reflecting positive market sentiment despite earlier intraday fluctuations. No specific news was identified to explain the movement.

Salīdzinājums

Cenas izmaiņa

Repligen Corp Prognoze

Cenas mērķis

By TipRanks

2.96% augšup

Prognoze 12 mēnešiem

Vidējais 172.45 USD  2.96%

Augstākais 207 USD

Zemākais 145 USD

Pamatojoties uz 13 Volstrītas analītiķiem, kuri piedāvā 12 mēnešu cenu mērķi Repligen Corp — pēdējo 3 mēnešu laikā.

Vērtējuma vienprātība

By TipRanks

Pirkt (spēcīgs)

13 ratings

12

Pirkt

1

Turēt

0

Pārdot

Noskaņojums

By Acuity

163 / 340 Rangs Veselības aprūpe

Ziņu noskaņojums

Neutral

Volatilitāte

Zem vidējā

Ziņu apjoms (RCV)

Virs vidējā

Finanšu rādītāji

Pārdošanas un administrēšanas izmaksas

Darbības izmaksas

Peļņa pirms nodokļu nomaksas

Pārdošana

Pārdošanas maksa

Bruto peļņa no pārdošanas

Procentu izdevumi par parādu

EBITDA

Pamatdarbības peļņa

$

Par Repligen Corp

Repligen Corporation develops and commercializes bioprocessing technologies and systems for use in biological drug manufacturing process in North America, Europe, the Asia Pacific, and internationally. It offers Protein A ligands that are the binding components of Protein A affinity chromatography resins; and cell culture growth factor products. The company's chromatography products include OPUS pre-packed chromatography columns, which are used in the purification of biologics; and OPUS smaller-scale columns that are used in the high throughput process development screening, viral clearance validation studies, and scale down validation of chromatography processes. It also offers ELISA test kits; and chromatography resins under the CaptivA brand. In addition, the company provides filtration products, such as XCell Alternating Tangential Flow systems that are filtration devices used in upstream perfusion and cell culture processing; TangenX flat sheet cassettes, which are used in downstream biologic drug concentration, buffer exchange, and formulation processes; KrosFlo tangential flow filtration and tangential flow depth filtration systems; Spectra/Por laboratory and process dialysis products, and ProConnex TFDF flow paths. Further, it provides process analytics products, such as slope spectroscopy systems under the SoloVPE, FlowVPE, and FlowVPX brands. The company sells its products to life sciences, biopharmaceutical, and diagnostics companies; laboratory researchers; and contract manufacturing organizations. Repligen Corporation has collaboration agreements with Navigo Proteins GmbH to develop multiple affinity ligands. The company was incorporated in 1981 and is headquartered in Waltham, Massachusetts.
help-icon Live chat